Literature DB >> 9404703

The cytotoxic effect of fleroxacin and ciprofloxacin on transitional cell carcinoma in vitro.

S Ebisuno1, T Inagaki, Y Kohjimoto, T Ohkawa.   

Abstract

BACKGROUND: There have been few reports concerning the cytotoxic effects of fluoroquinolone antibiotics on transitional cell carcinoma. This investigation was designed to study the cytotoxic effects of fleroxacin and ciprofloxacin on transitional cell carcinoma quantitatively in vitro.
METHODS: Two transitional cell carcinoma cell lines, MBT-2 and T24, were used in this study. The effects of fleroxacin and ciprofloxacin on cell proliferation were determined by counting the number of living cells and by colorimetric MTT assay.
RESULTS: Two fluoroquinolones, fleroxacin and ciprofloxacin, significantly inhibited cell proliferation in a dose-dependent manner at a concentration of 50-800 microg/mL in both cell lines. Compared with the cytotoxic effects of the two antibiotics, the inhibitory activity of ciprofloxacin on cell proliferation significantly exceeded that of fleroxacin in the MBT-2 cell line. However, the two fluoroquinolones did not have significantly different effects on the T24 cell line.
CONCLUSIONS: Fleroxacin and ciprofloxacin significantly affect cell proliferation in transitional cell carcinoma cell lines. The results encourage further study of the possibility of clinical application of some fluoroquinolones to prevent recurrence of urinary bladder tumors because the urinary excretions after oral administration of these drugs are quite high.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9404703

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

Review 1.  Chemoprevention of bladder cancer.

Authors:  Dragan J Golijanin; David Kakiashvili; Ralph R Madeb; Edward M Messing; Seth P Lerner
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

2.  Synthesis of novel tetrazole containing hybrid ciprofloxacin and pipemidic acid analogues and preliminary biological evaluation of their antibacterial and antiproliferative activity.

Authors:  Kommula Dileep; Sowjanya Polepalli; Nishant Jain; Sudheer Kumar Buddana; R S Prakasham; M S R Murty
Journal:  Mol Divers       Date:  2017-11-14       Impact factor: 2.943

Review 3.  Molecular pathways: microRNAs as cancer therapeutics.

Authors:  Sonia A Melo; Raghu Kalluri
Journal:  Clin Cancer Res       Date:  2012-06-18       Impact factor: 12.531

Review 4.  Quinolones as a Potential Drug in Genitourinary Cancer Treatment-A Literature Review.

Authors:  Tomasz Kloskowski; Sylwia Frąckowiak; Jan Adamowicz; Kamil Szeliski; Marta Rasmus; Tomasz Drewa; Marta Pokrywczyńska
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

5.  The anti-cancer effects of quinolone antibiotics?

Authors:  M Paul; A Gafter-Gvili; A Fraser; L Leibovici
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-11       Impact factor: 3.267

6.  Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells.

Authors:  C Herold; M Ocker; M Ganslmayer; H Gerauer; E G Hahn; D Schuppan
Journal:  Br J Cancer       Date:  2002-02-01       Impact factor: 7.640

7.  Extracellular Caspase-8 Dependent Apoptosis on HeLa Cancer Cells and MRC-5 Normal Cells by ICD-85 (Venom Derived Peptides).

Authors:  Abbas Zare-Mirakabadi; Ali Sarzaeem
Journal:  Iran J Cancer Prev       Date:  2012

8.  Necrotic Effect versus Apoptotic Nature of Camptothecin in Human Cervical Cancer Cells.

Authors:  Abbas Zare-Mirakabadi; Ali Sarzaeem; Saeed Moradhaseli; Aida Sayad; Masoud Negahdary
Journal:  Iran J Cancer Prev       Date:  2012

9.  Time- and concentration-dependent cytotoxicity of antibiotics used in endodontic therapy.

Authors:  Marina Beloti Ferreira; Suely Myiagi; Carlos Goes Nogales; Marcia Sampaio Campos; José Luiz Lage-Marques
Journal:  J Appl Oral Sci       Date:  2010 May-Jun       Impact factor: 2.698

10.  Urinary tract infections and reduced risk of bladder cancer in Los Angeles.

Authors:  X Jiang; J E Castelao; S Groshen; V K Cortessis; D Shibata; D V Conti; J-M Yuan; M C Pike; M Gago-Dominguez
Journal:  Br J Cancer       Date:  2009-01-27       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.